<ul data-eligibleForWebStory="false"><li>Varda Space Industries, a microgravity-enabled life sciences company, secured $187 million in a Series C funding round led by Natural Capital and Shrug Capital among other investors.</li><li>The total funding for Varda now amounts to $329 million, with successful launch and return missions and plans for more missions in 2023.</li><li>Varda's orbital laboratories process materials outside the International Space Station, leveraging the unique crystallization effects of microgravity to create novel drug formulations.</li><li>The company is expanding its terrestrial presence, opening a new laboratory facility in El Segundo and aiming to develop processes for in-space pharmaceutical manufacturing to drive the orbital economy.</li></ul>

Khosla Ventures, others invest $187 million in a startup that wants to make medicines in space

Discover more